Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

por Talbot, D C, Moiseyenko, V, Van Belle, S, O'Reilly, S M, Alba Conejo, E, Ackland, S, Eisenberg, P, Melnychuk, D, Pienkowski, T, Burger, H-U, Laws, S, Osterwalder, B
Publicado 2002

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission

por Goh, J, Mason, J, Chan, J, Moradi, M, Berek, J, Beningno, B, Mileshkin, L, Recio, F, Tchabo, N, Rossi, E, Eisenberg, P, Rose, P, Mitchell, P, Young, J, Matos, M, Secord, A, Davy, M, Gargosky, S, Gray, H
Publicado 2013